Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis Pharmaceuticals (APLS – Research Report).

Wells Fargo analyst Mohit Bansal maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target of $460.00. The company’s shares closed yesterday ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

He ordered the Vertex construction company to remove the soil that had been dumped there to ensure that the area of the nala did not decrease. In return, Vertex construction company representatives ...

Moreover, during the inspection, Vertex Construction Company has been instructed to clear the soil that was dumped in the area to maintain the mine’s size. The company has guaranteed that the ...

assert_edges(self.A.get_edges(), [self.B, self.C]) assert_edges(self.B.get_edges(), [self.A, self.D]) assert_edges(self.C.get_edges(), [self.A, self.D]) assert_edges ...